Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

2-fraction Stereotactic Body Proton Therapy (SBPT) With Magnetic Resonance Imaging (MRI) Guidance in Localized Prostate Cancer: A Single-arm Phase II Non-randomized Trial

NCT07130682 is registered in ClinicalTrials.gov with Hong Kong Sanatorium & Hospital as lead sponsor.

NCT NCT07130682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07130682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
2-fraction Stereotactic Body Proton Therapy (SBPT) With Magnetic Resonance Imaging (MRI) Guidance in Localized Prostate Cancer: A Single-arm Phase II Non-randomized Trial
Lead sponsor
Hong Kong Sanatorium & Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
September 1, 2025
Completion date
June 2, 2033
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer patients treated by radiotherapy